A newly published research review is raising serious questions about the integrity of one of the most widely used and commercially significant areas of autism intervention research. Published on May 10, 2026, in Psychology Today by Ludmila N. Praslova, PhD, professor of Organizational Psychology at Vanguard University of Southern California, the article examines a major 2026 update by Bottema-Beutel and colleagues that re-analyzed conflict-of-interest disclosures across eight Applied Behavior Analysis (ABA) journals. The findings are striking: nearly all the research used to support ABA as an autism intervention is authored by researchers with undisclosed financial interests in ABA’s continued use. For families, clinicians, and autistic individuals trying to make informed decisions, this is research that demands attention.
The Numbers Are Difficult to Ignore
The Bottema-Beutel team’s 2026 update is a follow-up to an earlier investigation they published in 2021, when they first sounded the alarm about widespread undisclosed conflicts of interest. Five years later, despite some journals updating their disclosure policies, the problem remains largely unchanged. The data is sobering:
78 percent of authors held clinical or consultancy conflicts of interest — they were paid ABA providers, paid ABA consultants, or both. 93 percent of studies had at least one such author. Only 8 percent of studies disclosed any conflicts. And perhaps the most striking finding: of all statements claiming no conflicts of interest, 93 percent were false.
As Praslova frames it directly, imagine being prescribed a medication only to learn that 93 percent of the studies supporting it were written by researchers holding financial stakes in the drug’s continued use — and that most of them said they had no conflicts of interest. Now replace “medication” with “Applied Behavior Analysis.” Would you not question every conclusion, every claim of benefit?
How Conflicts of Interest Actually Work
It is important to understand what a conflict of interest does not mean. As Praslova carefully notes, a conflict of interest does not mean researchers are lying or fabricating data. Most ABA researchers genuinely believe in the work they are doing. The problem is more subtle, and arguably more difficult to address.
Financial entanglement can systematically shape what questions get asked, which outcomes get measured, how data gets interpreted, and what gets written up and published. Researchers who make their living providing ABA have a structural incentive to design studies that favor ABA, to measure outcomes that ABA can move, and to define “success” in ways that protect the revenue model. What they may be less interested in doing is measuring potential negative outcomes of the intervention.
The Question of What Counts as a “Good Outcome”
This is where the conflict-of-interest issue becomes most consequential for autistic individuals and the families who care for them. In autism intervention research, what counts as a “good outcome” is itself a contested question. Eye contact? Compliance? Behavioral conformity?
Praslova raises a pointed question: are these ABA metrics favored, in part, because the people selecting them profit when those metrics move? Meanwhile, autistic people have long argued that these metrics target external “normalization” rather than genuine well-being — a critique supported by research showing that what the field chooses to measure can diverge sharply from what autistic people themselves report needing. Outcomes like autistic well-being, self-reported quality of life, identity development, and long-term psychological health have been systematically underrepresented in the evidence base.
When the researchers selecting outcome metrics are often the same people who are financially rewarded for outward behavior normalization rather than autistic well-being, the implications are difficult to dismiss.
The Testimony the Field Keeps Discounting
A central concept in Praslova’s analysis is epistemic injustice, a term developed by philosopher Miranda Fricker to describe what happens when someone is wronged specifically in their capacity as a knower — when their testimony is discounted, or their credibility is structurally undermined.
For decades, many autistic adults have reported that ABA caused them harm. Published research has documented evidence of increased PTSD symptoms in autistic individuals who underwent ABA, as well as concerns about excessive compliance behaviors as a long-term consequence. These accounts have been largely dismissed by the establishment scientific community.
The conflict-of-interest findings offer one explanation for that dismissal that is both troubling and logical: when 93 percent of authors’ conflict disclosures are false, the field becomes far less likely to produce neutral evidence — even if the intention to help autistic populations is genuine. And throughout this entire period, autistic people themselves have been largely absent from the rooms where research agendas are set, outcome measures are chosen, and editorial decisions are made.
What Genuinely Rigorous Autism Research Would Look Like
Praslova outlines what would be required to restore trust in ABA research and, more broadly, in autism intervention research. Three changes stand out as essential.
The first is transparency through verified conflict disclosure with real accountability — meaning journals must not only require disclosure but actively verify it and impose consequences for misrepresentation. The second is meaningful autistic participation in research design and outcome selection, ensuring that the people most affected by interventions have a genuine voice in determining what success looks like and what risks need to be measured. The third is a serious effort to investigate long-term psychological outcomes of autism interventions, including outcomes the field has historically been reluctant to examine.
Takeaway
This research raises questions every parent, clinician, and autistic individual deserves to have answered honestly. ABA is the most widely insurance-covered, school-implemented, and clinician-recommended autism intervention in the United States. Decisions about whether to use it are made every day in homes, schools, and clinics — often based on a body of research that, according to these findings, is significantly shaped by undisclosed financial interests. None of this means ABA is uniformly harmful, nor does it mean families who have used it made the wrong choice. What it does mean is that the evidence base being cited to support these decisions is far less neutral than it has been presented. For mental health professionals, clinicians, and parents, the responsible response is not panic but careful inquiry — asking harder questions, listening seriously to autistic voices that have been historically dismissed, and demanding the kind of transparent, independent, and autistic-informed research that this field has badly needed for decades.
Source: Read the Original Article
You can reach me at my website or call me directly at 832-559-3520 if you have any questions. Thank You!
- Heavy Social Media Use Linked to Anxiety in Medical Students - May 11, 2026
- Can We Trust the Research Behind ABA Autism Therapy? - May 11, 2026
- Are Girls Biologically Protected Against Autism? - April 29, 2026
